Biotech

All Articles

Novo inks $600M NanoVation bargain to research genetic medications ex-liver

.Novo Nordisk is continuing its press right into hereditary medicines, accepting to pay NanoVation T...

Innovent web links cytokine to intestines cancer feedbacks

.Innovent Biologics has actually produced the instance that its own checkpoint inhibitor-cytokine bl...

Merck, Daiichi ADC strikes target in period 3 bronchi cancer cells research

.A phase 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina strengthens artificial intelligence concentrate along with collab to select cancer aim ats

.5 months after Rakovina Therapeutics rotated towards expert system, the cancer-focused biotech has ...

Ascendis' dwarfism medication hits in phase 3, threatens BioMarin

.Ascendis Pharma has actually become a potential threat to BioMarin's Voxzogo, reporting phase 3 dev...

Despite ph. 3 miss, Alkeus sees road ahead of time for eye ailment property

.Though Alkeus Pharmaceuticals' oral eye condition resource neglected to substantially lessen geogra...

Kairos goes social along with $6M IPO to finance trials of cancer cells medicine

.Along with a triad of biotechs hitting the Nasdaq on Friday, it was actually easy to miss out on a ...

Vaccine as well as Keytruda combo successful in squamous tissue cancer

.Immune gate inhibitors are actually the superheroes of cancer treatment. Drugs like Bristol Myers S...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings ...

Regeneron's Opdualag rival reveals 57% action fee

.Regeneron is back with long-lasting follow-up for its LAG-3 prevention and also PD-1 prevention com...